Gene and genome editing最新文献

筛选
英文 中文
Genome editing technology and applications with the type I CRISPR system 基因组编辑技术及其与I型CRISPR系统的应用
Gene and genome editing Pub Date : 2022-12-01 DOI: 10.1016/j.ggedit.2022.100013
Kazuto Yoshimi , Tomoji Mashimo
{"title":"Genome editing technology and applications with the type I CRISPR system","authors":"Kazuto Yoshimi ,&nbsp;Tomoji Mashimo","doi":"10.1016/j.ggedit.2022.100013","DOIUrl":"10.1016/j.ggedit.2022.100013","url":null,"abstract":"<div><p>Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems, which are representative genome editing technologies, are classified into class 1 and class 2 in terms of evolutionary biology and are further classified into several subtypes. Class 2 CRISPR systems, including type II Cas9 and type V Cas12a, are the most commonly used for genome editing in eukaryotic cells, while type I CRISPR systems within Class 1 are also becoming available. Type I CRISPR recognizes longer target sequences than CRISPR-Cas9 and can induce large deletion mutations of several kilobases. These features demonstrate its potential as a novel and unique genome editing tool that can induce genetic disruption safely and reliably. Thus, it is expected to be utilized for gene therapy and industrial applications. Recently, the DNA cleavage mechanism of type I CRISPR has also revealed details from protein-complex analyses with X-ray crystallography, cryo-electron microscopy, and high-speed atomic force microscopy. The single-strand DNA trans-cleavage activity of type I CRISPR, called collateral activity, has broadened the potential application for CRISPR diagnostics, especially in the development of point-of-care testing methods for COVID-19. In this review, we present an overview of the type I CRISPR system, its application to genome editing, and genetic diagnosis using CRISPR-Cas3.</p></div>","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"3 ","pages":"Article 100013"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266638802200003X/pdfft?md5=8eab8b309522c5e7bbddba69bc0770e0&pid=1-s2.0-S266638802200003X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43940303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Genome editing in mice and its application to the study of spermatogenesis 小鼠基因组编辑及其在精子发生研究中的应用
Gene and genome editing Pub Date : 2022-12-01 DOI: 10.1016/j.ggedit.2022.100014
Seiya Oura , Hideto Mori , Masahito Ikawa
{"title":"Genome editing in mice and its application to the study of spermatogenesis","authors":"Seiya Oura ,&nbsp;Hideto Mori ,&nbsp;Masahito Ikawa","doi":"10.1016/j.ggedit.2022.100014","DOIUrl":"10.1016/j.ggedit.2022.100014","url":null,"abstract":"<div><p>Gene modification technology has long been beneficial for unraveling the mystery of biological phenomena. Thus, the advent of the clustered regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated (Cas) 9 system was a game-changer in biological research because of its efficiency and simplicity of design. This review article first describes a brief guideline of gRNA design and the methods to incorporate the CRISPR/Cas9 system into zygotes. Then, we will also discuss the application of this technology to the study of male reproductive biology, including knock-out (KO) phenotypical screening of genes expressed in the male reproductive tissues.</p></div>","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"3 ","pages":"Article 100014"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666388022000041/pdfft?md5=c8b36d0f294a2356a30167622ac7c601&pid=1-s2.0-S2666388022000041-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44631995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of DNA Ink & DNA Barcoding Technology on Practical Tracking & Authenticity Detection of Pharmaceutical Ingredients DNA墨水及DNA条形码技术在药物成分实用化跟踪与真实性检测中的发展
Gene and genome editing Pub Date : 2022-01-01 DOI: 10.29228/genediting.66978
Buket Budaklar, Berranur Sert, Gamze Gülden, Cihan Tastan
{"title":"Development of DNA Ink & DNA Barcoding Technology on Practical Tracking & Authenticity Detection of Pharmaceutical Ingredients","authors":"Buket Budaklar, Berranur Sert, Gamze Gülden, Cihan Tastan","doi":"10.29228/genediting.66978","DOIUrl":"https://doi.org/10.29228/genediting.66978","url":null,"abstract":"","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76956717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene Therapy Products Approved in 2022 基因治疗产品于2022年获批
Gene and genome editing Pub Date : 2022-01-01 DOI: 10.29228/genediting.67056
Sümbül Yıldırım
{"title":"Gene Therapy Products Approved in 2022","authors":"Sümbül Yıldırım","doi":"10.29228/genediting.67056","DOIUrl":"https://doi.org/10.29228/genediting.67056","url":null,"abstract":"","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77092954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene editing tools and the treatment of cystic fibrosis disease 基因编辑工具和囊性纤维化疾病的治疗
Gene and genome editing Pub Date : 2022-01-01 DOI: 10.29228/genediting.63292
Heliya Ashouri
{"title":"Gene editing tools and the treatment of cystic fibrosis disease","authors":"Heliya Ashouri","doi":"10.29228/genediting.63292","DOIUrl":"https://doi.org/10.29228/genediting.63292","url":null,"abstract":"","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"11 suppl_1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86761290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The CRISPR-Cas12 SHERLOCK System Can Identify HIV CRISPR-Cas12 SHERLOCK系统可以识别HIV
Gene and genome editing Pub Date : 2022-01-01 DOI: 10.29228/genediting.66981
Cemre Can İnci, Gamze Gülden, Berranur Sert, Cihan Tastan
{"title":"The CRISPR-Cas12 SHERLOCK System Can Identify HIV","authors":"Cemre Can İnci, Gamze Gülden, Berranur Sert, Cihan Tastan","doi":"10.29228/genediting.66981","DOIUrl":"https://doi.org/10.29228/genediting.66981","url":null,"abstract":"","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89614023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression of Axolotl P53 Gene May Increase Cancer Resistance 蝾螈P53基因的表达可能增强肿瘤抵抗能力
Gene and genome editing Pub Date : 2022-01-01 DOI: 10.29228/genediting.66929
Hale Ahsen Babar, Özüm Kılıç, Gamze Gülden, Berranur Sert, Cihan Tastan
{"title":"Expression of Axolotl P53 Gene May Increase Cancer Resistance","authors":"Hale Ahsen Babar, Özüm Kılıç, Gamze Gülden, Berranur Sert, Cihan Tastan","doi":"10.29228/genediting.66929","DOIUrl":"https://doi.org/10.29228/genediting.66929","url":null,"abstract":"","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89127936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TALE and TALEN genome editing technologies TALE和TALEN基因组编辑技术
Gene and genome editing Pub Date : 2021-12-01 DOI: 10.1016/j.ggedit.2021.100007
Sebastian Becker, Jens Boch
{"title":"TALE and TALEN genome editing technologies","authors":"Sebastian Becker,&nbsp;Jens Boch","doi":"10.1016/j.ggedit.2021.100007","DOIUrl":"10.1016/j.ggedit.2021.100007","url":null,"abstract":"<div><p>TALEN were the first easy-to-use genome editing technology and sparked the genome editing revolution. Their application in multiple species brought targeted mutagenesis to the attention of scientists worldwide. Key breakthrough successes of genome editing have since been achieved using TALEN, among these, the first commercialization of an edited crop and the first human cured from cancer. TALEN have since been largely replaced by the CRISPR technologies which are somewhat easier to build, much easier to multiplex, and have spawned multiple derived techniques. Nevertheless, the flexible and precise positioning of TALEN is unmatched, and thus they have continued to evolve to new functionalities. Here, we assemble essential facts, design guidelines as well as important past and exciting novel developments.</p></div>","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"2 ","pages":"Article 100007"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ggedit.2021.100007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113115832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 38
Moving from in vitro to in vivo CRISPR screens 从体外到体内的CRISPR筛选
Gene and genome editing Pub Date : 2021-12-01 DOI: 10.1016/j.ggedit.2021.100008
Maria Kuhn , António J. Santinha , Randall J. Platt
{"title":"Moving from in vitro to in vivo CRISPR screens","authors":"Maria Kuhn ,&nbsp;António J. Santinha ,&nbsp;Randall J. Platt","doi":"10.1016/j.ggedit.2021.100008","DOIUrl":"https://doi.org/10.1016/j.ggedit.2021.100008","url":null,"abstract":"<div><p>Clustered regularly interspaced short palindromic repeats (CRISPR) screens emerged as the gold standard technology in genetic screening in recent years. Most CRISPR screens are conducted in vitro, although current technologies fail to completely recapitulate the in vivo physiological environment. Direct in vivo screening - where cells are targeted within their natural niche - is emerging as a powerful approach to unravel biological processes in intact tissues and organs, taking into account complex cellular interactions, immune response, extracellular matrix, and tissue architecture. Several recent studies have demonstrated the capacity of in vivo screens to identify unique genetic dependencies left uncovered by in vitro screens. Together with new single cell readout techniques, in vivo CRISPR screens will continue to fuel progress towards identifying genetic elements controlling development, health, and disease.</p></div>","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"2 ","pages":"Article 100008"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ggedit.2021.100008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136433584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
Genome editing of therapeutic T cells 治疗性T细胞的基因组编辑
Gene and genome editing Pub Date : 2021-12-01 DOI: 10.1016/j.ggedit.2021.100010
Waseem Qasim
{"title":"Genome editing of therapeutic T cells","authors":"Waseem Qasim","doi":"10.1016/j.ggedit.2021.100010","DOIUrl":"10.1016/j.ggedit.2021.100010","url":null,"abstract":"<div><p>The potential of engineered TCRαβ T cells as potent mediators of leukemic clearance has been demonstrated in clinical trials, and authorised therapies are being deployed against B cell malignancies in particular. While most applications have relied on harvest and manipulation of autologous lymphocytes, the emerging application of genome editing technology has demonstrated that allogeneic TCRαβ cells can be engineered to overcome Human Leukocyte Antigen (HLA) barriers and provides a route to more cost effective and widely accessible ‘off-the-shelf’ therapies. Genome editing also offers the prospect of addressing other hurdles such as shared-antigen expression and has been applied to direct site-specific transgene integration, for improved transcriptional regulation and function.</p></div>","PeriodicalId":73137,"journal":{"name":"Gene and genome editing","volume":"2 ","pages":"Article 100010"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ggedit.2021.100010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39780167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信